Developing the next generation of cancer vaccines News & Announcements February 22, 2024: RealLIST Startups 2024: Discover the 20 Baltimore startups shaping tomorrow’s entrepreneurial landscapeDecember 20, 2023: Baltimore Money Moves: Biotech wins big (again)December 19, 2023: USM Maryland Momentum Fund and University of Maryland, Baltimore invest in Irazu Oncology, joining Wexford SciTech Venture Fund, Abell Foundation, and other leading investors (UM Ventures)December 19, 2023: Irazu Oncology secures $2.6M seed investment to advance innovative cancer vaccine platformDecember 18, 2023: Irazu Oncology secures $2.6M debt to advance UMB’s vaccine Technology (Biohealth Innovation)November 7, 2023: Irazu Oncology and University of Maryland, Baltimore mark anniversary of exclusive license for development of colorectal cancer vaccineAugust 28, 2023: Irazu Oncology receives funding from TEDCO’s Maryland Innovation Initiative (MII) to support efforts to develop and commercialize its vaccine platformJune 27, 2023: BIO Delegation gave these Maryland companies access to investors, customers & collaboratorsJune 5, 2023: Irazu Oncology is selected as a Maryland BIO Delegate and attends BIO Boston